Vir Biotechnology Inc. (VIR) and GlaxoSmithKline's (GSK) Sotrovimab Retains Activity Against Key Omicron Mutations, per Preclinical Data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/10/2026

1. COO
2. CHWY
3. AVAV
4. SPY
5. ASO
6. AAPL
7. USO
8. NVDA
9. PLTR
10. NAVN

Go back to Vir Biotechnology Inc. (VIR) and GlaxoSmithKline's (GSK) Sotrovimab Retains Activity Against Key Omicron Mutations, per Preclinical Data
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 48.07 -0.56 (1.15%)
Previous Close $48.63    52 Week High $45.58 
Open $48.47    52 Week Low $37.82 
Day High $48.59    P/E N/A 
Day Low $47.98    EPS $0.00 
Volume 1,506,082       

(NASDAQ: VIR) Delayed: 10.68 -0.13 (1.2%)
Previous Close $10.81    52 Week High $ 
Open $10.57    52 Week Low $ 
Day High $10.79    P/E N/A 
Day Low $10.45    EPS $ 
Volume 1,015,354